ATE190627T1 - Verwendung von igf-bp zur rückfaltung von igf - Google Patents

Verwendung von igf-bp zur rückfaltung von igf

Info

Publication number
ATE190627T1
ATE190627T1 AT95901661T AT95901661T ATE190627T1 AT E190627 T1 ATE190627 T1 AT E190627T1 AT 95901661 T AT95901661 T AT 95901661T AT 95901661 T AT95901661 T AT 95901661T AT E190627 T1 ATE190627 T1 AT E190627T1
Authority
AT
Austria
Prior art keywords
igf
pct
refold
date
insulin
Prior art date
Application number
AT95901661T
Other languages
English (en)
Inventor
Bjoern Nilsson
Sophia Elisabeth Hober
Original Assignee
Chiron Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chiron Corp filed Critical Chiron Corp
Application granted granted Critical
Publication of ATE190627T1 publication Critical patent/ATE190627T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/65—Insulin-like growth factors, i.e. somatomedins, e.g. IGF-1, IGF-2

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Endocrinology (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Diabetes (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AT95901661T 1993-11-16 1994-11-14 Verwendung von igf-bp zur rückfaltung von igf ATE190627T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9303784A SE9303784D0 (sv) 1993-11-16 1993-11-16 Igf
PCT/SE1994/001076 WO1995014034A1 (en) 1993-11-16 1994-11-14 Use of igf-bp for refolding of igf

Publications (1)

Publication Number Publication Date
ATE190627T1 true ATE190627T1 (de) 2000-04-15

Family

ID=20391767

Family Applications (1)

Application Number Title Priority Date Filing Date
AT95901661T ATE190627T1 (de) 1993-11-16 1994-11-14 Verwendung von igf-bp zur rückfaltung von igf

Country Status (12)

Country Link
US (1) US5683980A (de)
EP (1) EP0736040B1 (de)
JP (1) JP3609410B2 (de)
AT (1) ATE190627T1 (de)
AU (1) AU684117B2 (de)
CA (1) CA2176599A1 (de)
DE (1) DE69423516T2 (de)
FI (1) FI962081A7 (de)
NO (1) NO961995L (de)
NZ (1) NZ276520A (de)
SE (1) SE9303784D0 (de)
WO (1) WO1995014034A1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5789547A (en) * 1995-06-07 1998-08-04 Celtrix Pharmaceuticals, Inc. Method of producing insulin-like growth factor-I (IGF-I) and insulin-like growth factor binding protein-3 (IGFBP-3) with correct folding and disulfide bonding
US6417330B1 (en) 1998-06-01 2002-07-09 Celtrix Pharmaceuticals, Inc. Insulin-like growth factor binding protein variants
JP3734634B2 (ja) * 1999-03-03 2006-01-11 ヒゲタ醤油株式会社 タンパク質の活性化方法及び該装置
KR20020074749A (ko) * 2001-03-21 2002-10-04 한국생명공학연구원 재조합 인슐린 유사성장인자-1의 대량 생산방법

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8826451D0 (en) * 1988-11-11 1988-12-14 Sandoz Ltd Improvements in/relating to organic compounds
US5158875A (en) * 1989-08-25 1992-10-27 Amgen Inc. Production of biologically active insulin-like growth factor i from high expression host cell systems
WO1992014834A1 (en) * 1991-02-14 1992-09-03 The Whittier Institute For Diabetes And Endocrinology Insulin-like growth factor binding protein
US5288931A (en) * 1991-12-06 1994-02-22 Genentech, Inc. Method for refolding insoluble, misfolded insulin-like growth factor-I into an active conformation
AU3812993A (en) * 1992-03-24 1993-10-21 Synergen, Inc. Refolding and purification of insulin-like growth factor I
US5407913A (en) * 1992-12-03 1995-04-18 Celtrix Pharmaceuticals, Inc. Method and composition for systemic treatment of tissue injury

Also Published As

Publication number Publication date
FI962081A0 (fi) 1996-05-15
EP0736040B1 (de) 2000-03-15
NZ276520A (en) 1997-11-24
FI962081L (fi) 1996-07-15
WO1995014034A1 (en) 1995-05-26
DE69423516D1 (de) 2000-04-20
NO961995D0 (no) 1996-05-15
FI962081A7 (fi) 1996-07-15
AU1080895A (en) 1995-06-06
EP0736040A1 (de) 1996-10-09
US5683980A (en) 1997-11-04
CA2176599A1 (en) 1995-05-26
SE9303784D0 (sv) 1993-11-16
AU684117B2 (en) 1997-12-04
JP3609410B2 (ja) 2005-01-12
JPH09505077A (ja) 1997-05-20
NO961995L (no) 1996-05-15
DE69423516T2 (de) 2000-09-14

Similar Documents

Publication Publication Date Title
FR2678624B1 (de)
ATE81779T1 (de) Peptidanalogedes insulinaehnlichen wachstumsfaktors-1 bei saeugetieren.
ATE80660T1 (de) Verfahren zur herstellung eines polypeptides.
DK0477971T3 (da) Humant CNP gen og precursorprotein
ATE295414T1 (de) Menschliche ctla-8 und verwendung von ctla-8 ähnlichen proteinen
DE69228705D1 (de) Methode zur rückfaltung von igf-i in eine aktive konformation
ATE125869T1 (de) Wachstumshormonfusionsproteine.
DK0643767T3 (da) Osteogene peptider
DK0479948T3 (da) Sammensætninger og fremgangsmåder til syntese af natriuretisk protein-receptor B og anvendelsesfremgangsmåder
ATE389416T1 (de) Behandlung von knorpelerkrankungen
ATE175978T1 (de) Verwendung von spezifischen molekülen zur steigerung der igf-1 aktivität
ATE301714T1 (de) Insulinartigen wachstumsfaktor bindendes protein -3 variante
DE69423516D1 (de) Verwendung von igf-bp zur rückfaltung von igf
ATE154362T1 (de) Verfahren zur herstellung von pai-2
ATE190499T1 (de) Methode zur behandlung von reproduktionserkrankungen
DE69333063D1 (de) Vekürztes insulinähnlichen wachstumsfaktor-bindendes protein mit mitogener aktivität
CO4700528A1 (es) Peptidos de somatostatina
DE69233155D1 (de) Insulinartigen wachstumsfaktor bindendes protein
DE69028711D1 (de) Verfahren zur proteinreinigung
DE69133340D1 (de) Neue type-i-interferon varianten, ihre verfahren zur herstellung, und ihre verwendungen
ATE180679T1 (de) Neue verbesserungen hinsichtlich der radiomarkierung von proteinen
DE3873273D1 (de) Verfahren zur selektiven spaltung von fusionsproteinen.
CA2074182A1 (en) Process for the reactivation of denatured protein
ATE179989T1 (de) Peptide zur behandlung von allergien
ES8504256A1 (es) Metodo para obtener polipeptidos

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties